Expected Revenue, page-310

A lot of backpedaling by some

was all about ces launch of gen 4,
oems which would build on the back of the nearly 5000 pos

sure you can’t launch a medical device without dad approval, but the mantra was its in production already , feedback issue wasn’t an issue and come ces deals would be done

now it’s not approved and it was a showing

non of that mentioned in the lead up to capital raising, in fact when the capital raising was so poorly supported and came up short - forget that here comes ces , gen4 and some oem deals

Cash balance doesn’t support another 6 -9 months approval wait time- will all be eaten by insane executive salaries and more will be needed for manufacturing and launch- so get ready for more dilution, secured creditor is owed 2.5 million - all they got is gen 2 rebadged gen3 with Hp on it and a non approved gen 4 single chip bud which isn’t being sold or even manufactured yet because it’s not approved by fda yet